Total Payments
$10,365
2024 Payments
$294.27
Companies
11
Transactions
33
Medicare Patients
539
Medicare Billing
$95,103
Payment Breakdown by Category
Consulting$7,200 (69.5%)
Research$2,500 (24.1%)
Food & Beverage$664.66 (6.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,200 | 2 | 69.5% |
| Unspecified | $2,500 | 1 | 24.1% |
| Food and Beverage | $664.66 | 30 | 6.4% |
Payments by Type
General
$7,865
32 transactions
Research
$2,500
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collagen Matrix, Inc | $9,853 | 10 | $0 (2020) |
| Daiichi Sankyo Inc. | $247.42 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $74.62 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $59.52 | 3 | $0 (2024) |
| GENZYME CORPORATION | $23.39 | 1 | $0 (2023) |
| EISAI INC. | $22.58 | 1 | $0 (2022) |
| Seagen Inc. | $22.17 | 1 | $0 (2021) |
| Sirtex Medical Inc | $16.34 | 1 | $0 (2019) |
| Octapharma USA, Inc. | $15.47 | 1 | $0 (2023) |
| Genentech USA, Inc. | $15.38 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $294.27 | 12 | Daiichi Sankyo Inc. ($202.58) |
| 2023 | $138.59 | 7 | Daiichi Sankyo Inc. ($44.84) |
| 2022 | $40.22 | 2 | EISAI INC. ($22.58) |
| 2021 | $22.17 | 1 | Seagen Inc. ($22.17) |
| 2020 | $6,500 | 1 | Collagen Matrix, Inc ($6,500) |
| 2019 | $3,279 | 5 | Collagen Matrix, Inc ($3,263) |
| 2018 | $31.63 | 2 | Collagen Matrix, Inc ($31.63) |
| 2017 | $58.73 | 3 | Collagen Matrix, Inc ($58.73) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Genentech USA, Inc. | Alecensa (Biological), Tecentriq, Tecentriq Hybreza | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: BioOncology | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $42.32 | General |
| Category: ONCOLOGY | ||||||
| 07/16/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: ONCOLOGY | ||||||
| 05/03/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Oncology | ||||||
| 01/19/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Oncology | ||||||
| 10/03/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Oncology | ||||||
| 09/04/2023 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: ONCOLOGY | ||||||
| 05/18/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Oncology | ||||||
| 01/31/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| Category: Oncology | ||||||
| 08/04/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $22.58 | General |
| Category: Oncology | ||||||
| 06/22/2022 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Oncology | ||||||
| 09/21/2021 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Oncology | ||||||
| 02/11/2020 | Collagen Matrix, Inc | — | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
| 07/16/2019 | Collagen Matrix, Inc | — | — | Cash or cash equivalent | $2,500.00 | Research |
| Study: Synoss Putty Clinical Study | ||||||
| 07/10/2019 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $16.34 | General |
| Category: Interventional Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Synoss Putty Clinical Study | Collagen Matrix, Inc | $2,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 97 | 208 | $84,232 | $18,722 |
| 2022 | 5 | 117 | 209 | $72,820 | $18,865 |
| 2021 | 7 | 139 | 269 | $94,548 | $23,700 |
| 2020 | 7 | 186 | 401 | $144,539 | $33,816 |
Total Patients
539
Total Services
1,087
Medicare Billing
$95,103
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 42 | 126 | $53,550 | $11,097 | 20.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $18,150 | $2,828 | 15.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 17 | 26 | $6,344 | $2,553 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 34 | $6,188 | $2,244 | 36.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 94 | $37,130 | $7,388 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 26 | 51 | $9,282 | $3,546 | 38.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 23 | 32 | $7,808 | $3,360 | 43.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $13,770 | $2,706 | 19.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 14 | 14 | $4,830 | $1,866 | 38.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 42 | 141 | $54,990 | $11,384 | 20.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 21 | 29 | $7,076 | $3,269 | 46.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $13,500 | $2,817 | 20.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 29 | $5,278 | $2,057 | 39.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 14 | 14 | $4,830 | $1,976 | 40.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 23 | $6,210 | $1,276 | 20.5% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 14 | 15 | $2,664 | $920.85 | 34.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 73 | 250 | $92,500 | $20,428 | 22.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 35 | 37 | $26,440 | $5,539 | 21.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 25 | 40 | $7,280 | $2,255 | 31.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 32 | $8,310 | $1,782 | 21.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 11 | 11 | $3,795 | $1,464 | 38.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 13 | 16 | $3,904 | $1,412 | 36.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 11 | 15 | $2,310 | $936.45 | 40.5% |
About Dr. Robert Horowitz, MD
Dr. Robert Horowitz, MD is a Hospice and Palliative Medicine healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780662445.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Horowitz, MD has received a total of $10,365 in payments from pharmaceutical and medical device companies, with $294.27 received in 2024. These payments were reported across 33 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($7,200).
As a Medicare-enrolled provider, Horowitz has provided services to 539 Medicare beneficiaries, totaling 1,087 services with total Medicare billing of $95,103. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospice and Palliative Medicine
- Other Specialties Internal Medicine
- Location Rochester, NY
- Active Since 01/04/2006
- Last Updated 07/05/2023
- Taxonomy Code 207RH0002X
- Entity Type Individual
- NPI Number 1780662445
Products in Payments
- Enhertu (Drug) $247.42
- ENHERTU (Biological) $59.52
- DARZALEX (Biological) $33.99
- SARCLISA (Biological) $23.39
- CARVYKTI (Drug) $22.99
- Lenvima (Drug) $22.58
- TUKYSA (Drug) $22.17
- RYBREVANT (Drug) $17.64
- SIR-Spheres Microspheres (Device) $16.34
- PANZYGA (Biological) $15.47
- Alecensa (Biological) $15.38
- OPDIVO (Biological) $14.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospice and Palliative Medicine Doctors in Rochester
Dr. Joseph Nicholas, M.d, M.D
Hospice and Palliative Medicine — Payments: $1,798
Hospice and Palliative Medicine $1,798
Joshua Jones, Md, MD
Hospice and Palliative Medicine — Payments: $399.42
Hospice and Palliative Medicine $399.42
Daniel Mulkerin, Md, MD
Hospice and Palliative Medicine — Payments: $393.75
Hospice and Palliative Medicine $393.75
Paul Cabral, Md, MD
Hospice and Palliative Medicine — Payments: $360.08
Hospice and Palliative Medicine $360.08
Dr. Julia Smith, M.d, M.D
Hospice and Palliative Medicine — Payments: $180.20
Hospice and Palliative Medicine $180.20
Dr. Thomas Carroll, M.d., Ph.d, M.D., PH.D
Hospice and Palliative Medicine — Payments: $164.67
Hospice and Palliative Medicine $164.67